Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crh Public (CRH) Total Non-Current Liabilities (2016 - 2025)

Crh Public (CRH) has disclosed Total Non-Current Liabilities for 9 consecutive years, with -$2.8 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Non-Current Liabilities changed N/A year-over-year to -$2.8 billion, compared with a TTM value of -$2.8 billion through Sep 2025, changed N/A, and an annual FY2024 reading of $25.4 billion, up 1.45% over the prior year.
  • Total Non-Current Liabilities was -$2.8 billion for Q3 2025 at Crh Public, down from $25.4 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $25.4 billion in Q4 2024 and bottomed at -$23.3 billion in Q2 2024.
  • Average Total Non-Current Liabilities over 5 years is $10.8 billion, with a median of $16.2 billion recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 79.63% in 2023, then tumbled 207.98% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $16.2 billion in 2021, then fell by 13.68% to $14.0 billion in 2022, then surged by 79.63% to $25.1 billion in 2023, then increased by 1.45% to $25.4 billion in 2024, then crashed by 110.95% to -$2.8 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for CRH at -$2.8 billion in Q3 2025, $25.4 billion in Q4 2024, and -$23.3 billion in Q2 2024.